Agilon Health Inc (AGL)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
CEO:
Steven J. Sell
Employees:
650
1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH, CA 90831
562-256-3800

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members.

Data derived from most recent annual or quarterly report
Market Cap 11.697 Billion Shares Outstanding411.855 Million Avg 30-day Volume 2.83 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue2.4325 Debt to Equity0.0418 EBITDA-81.934 Million
Price to Book Value6.3268 Operating Margin-4.4469 Enterprise Value5.711 Billion
Current Ratio2.712 EPS Growth0 Quick Ratio2.629
1 Yr BETA 1.0555 52-week High/Low 28.98 / 14.82 Profit Margin-3.9459
Operating Cash Flow Growth11.7111 Altman Z-Score7.1967 Free Cash Flow to Firm -163.635 Million
Earnings Report2023-05-04

Are you looking for this stock instead?

View SEC Filings from AGL instead.

View recent insider trading info

Funds Holding AGL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-01-09:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-12-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-24:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Proposed Sales (Form 144)

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    444.9 Thousand total shares from 16 transactions

    Exercise Derivative Conversion (M)

    524.9 Thousand total shares from 15 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DESAI VEERAL CHIEF STRATEGY & DEV. OFFICER

    • Officer
    276,729 2023-03-16 8

    KORNITZER BENJAMIN CHIEF MED. & QUALITY OFFICER

    • Officer
    55,426 2023-03-15 28

    SHAKER BENJAMIN CHIEF MARKETS OFFICER

    • Officer
    60,625 2023-03-15 11

    WULF JOHN WILLIAM

    • Director
    123,392 2023-03-15 2

    MCKENZIE DIANA

    • Director
    1,078 2023-02-17 2

    SELL STEVEN CEO & PRESIDENT

    • Officer
    • Director
    51,665 2022-11-18 2

    KASENCHAK PRISCILLA CHIEF ACCOUNTING OFFICER

    • Officer
    8,765 2022-10-03 2

    CD&R INVESTMENT ASSOCIATES IX, LTD.

    CD&R VECTOR HOLDINGS, L.P.

    • 10% Owner
    194,611,308 2022-08-11 1

    SCHWANEKE JEFFREY A.

    • Director
    0 2022-08-10 2

    SMITH MICHAEL L

    • Director
    163,118 2022-05-25 2

    WILLIAMS RONALD A

    • Director
    2,458,792 2022-04-14 1

    MANSUKANI SHARAD

    • Director
    1,236,292 2022-04-14 1

    MCLOUGHLIN KAREN

    • Director
    10,425 2022-04-14 1

    BENSLEY TIMOTHY CHIEF FINANCIAL OFFICER

    • Officer
    73,071 2022-04-14 2

    VENKATACHALIAH GIRISH CHIEF TECHNOLOGY OFFICER

    • Officer
    51,935 2022-04-14 2

    SOBOTKA GLENN CHIEF ACCOUNTING OFFICER

    • Officer
    5,365 2022-04-14 2

    GOURDINE MICHELLE A

    • Director
    18,892 2022-04-14 1

    RICHARDS CLAY

    • Director
    35,592 2022-04-14 1

    HALKIAS THEODORE CHIEF BUSINESS OFFICER

    • Officer
    3,414,924 2021-12-30 0

    DANIELEY JOAN CHIEF ADMINISTRATIVE OFFICER

    • Officer
    55,434 2021-12-17 0

    DOMBRO LISA EXPER. & INNOVATION OFFICER

    • Officer
    450,413 2021-09-14 0

    SCHNALL RICHARD J

    • Director
    0 2021-09-09 0

    SHLANTA PAUL R EVP, GC & CECO

    • Officer
    32,267 2011-10-24 0

    WOLF HENRY C

    • Director
    9,549 2010-12-15 0

    TUMMINELLO PETER I PRES., SEQUENT ENERGY MGMT.

    • Officer
    20,198 2010-11-09 0

    PIRATE CAPITAL LLC

    HUDSON THOMAS R JR

    • 10% Owner
    1,173,847 2007-04-30 0

    STEEL PARTNERS II LP

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G

    • 10% Owner
    1,842,150 2007-04-27 0

    OHARA STEPHEN M CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    90,856 2007-02-16 0

    FREY STEVEN L VP, GENERAL COUNSEL & SEC.

    • Officer
    24,017 2007-02-16 0

    SHAFFER JAMES W VP & CFO

    • Officer
    23,450 2007-02-16 0

    OLBRYCH JOHN S SENIOR VICE PRESIDENT

    • Officer
    4,731 2007-02-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DESAI VEERAL - Officer CHIEF STRATEGY & DEV. OFFICER

    2023-03-17 16:54:25 -0400 2023-03-16 M 60,000 d 1,640,000 direct

    DESAI VEERAL - Officer CHIEF STRATEGY & DEV. OFFICER

    2023-03-17 16:54:25 -0400 2023-03-16 S 60,000 $26.09 d 276,729 direct yes 3.7918 3.7918 2 0.0 1

    DESAI VEERAL - Officer CHIEF STRATEGY & DEV. OFFICER

    2023-03-17 16:54:25 -0400 2023-03-16 M 60,000 $3.00 a 336,729 direct 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-16 S 4,588 $24.36 d 81,037 direct yes 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-16 S 9,831 $25.65 d 71,206 direct yes 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-16 S 10,581 $26.08 d 60,625 direct yes 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-16 M 25,000 d 1,851 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-16 M 25,000 $1.00 a 85,625 direct 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 S 25,000 $23.80 d 60,625 direct yes 3.7918 3.7918 2 0.0 1

    WULF JOHN WILLIAM - Director

    2023-03-17 16:56:23 -0400 2023-03-15 M 80,000 $4.50 a 203,392 direct 3.7918 3.7918 2 0.0 1

    WULF JOHN WILLIAM - Director

    2023-03-17 16:56:23 -0400 2023-03-15 S 80,000 $23.82 d 123,392 direct 3.7918 3.7918 2 0.0 1

    WULF JOHN WILLIAM - Director

    2023-03-17 16:56:23 -0400 2023-03-15 M 80,000 d 120,000 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 M 25,000 $1.00 a 120,625 direct 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 M 25,000 d 26,851 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 S 35,000 $23.81 d 85,625 direct 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 M 70,000 $1.00 a 95,625 direct 3.7918 3.7918 2 0.0 1

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-03-17 16:55:46 -0400 2023-03-15 M 70,000 d 257,306 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-17 16:55:15 -0400 2023-03-15 S 55,000 $23.81 d 55,426 direct 3.7918 3.7918 2 0.0 1

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-17 16:55:15 -0400 2023-03-15 M 100,000 $4.49 a 110,426 direct 3.7918 3.7918 2 0.0 1

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-17 16:55:15 -0400 2023-03-15 M 100,000 d 175,000 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-08 M 8,094 d 141,188 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-08 M 8,094 $8.99 a 18,520 direct 0.9632 16.9002 16.9002 6 0.0 1

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-08 S 8,094 $24.44 d 10,426 direct yes 0.9632 16.9002 16.9002 6 0.0 1

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-07 S 8,094 $24.36 d 10,426 direct yes 0.9632 16.9002 16.9002 6 0.0 1

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-07 M 8,094 d 149,282 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-03-09 16:44:56 -0500 2023-03-07 M 8,094 $8.99 a 18,520 direct 0.9632 16.9002 16.9002 6 0.0 1

    MCKENZIE DIANA - Director

    2023-02-22 17:20:06 -0500 2023-02-17 A 11,104 a 11,104 direct

    MCKENZIE DIANA - Director

    2023-02-22 17:20:06 -0500 2023-02-17 A 1,078 a 1,078 direct -1.2161 14.4528 14.4528 6 -1.3564 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-15 M 8,094 $8.99 a 18,520 direct -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-15 S 8,094 $22.98 d 10,426 direct yes -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-15 M 8,094 d 157,376 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-15 M 28,555 d 51,851 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-15 S 28,555 $23.37 d 25,625 direct yes -2.4572 -7.1523 0.0 1 -7.3278 5

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-15 M 28,555 $1.00 a 54,180 direct -2.4572 -7.1523 0.0 1 -7.3278 5

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-14 M 19,594 $1.00 a 75,625 direct -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-14 M 25,881 $8.99 a 36,307 direct -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-14 S 25,881 $22.99 d 10,426 direct yes -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-16 17:37:53 -0500 2023-02-14 M 25,881 d 165,470 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-14 M 19,594 d 80,406 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-14 M 30,406 $3.00 a 56,031 direct -2.4572 -7.1523 0.0 1 -7.3278 5

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-14 M 30,406 d 0 direct

    SHAKER BENJAMIN - Officer CHIEF MARKETS OFFICER

    2023-02-16 17:38:29 -0500 2023-02-14 S 50,000 $22.98 d 25,625 direct yes -2.4572 -7.1523 0.0 1 -7.3278 5

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-02 M 30,782 d 191,351 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-02 S 30,782 $22.99 d 10,426 direct yes 4.3724 7.5223 31.2647 31.2647 31 -0.8463 17

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-02 M 30,782 $8.99 a 41,208 direct 4.3724 7.5223 31.2647 31.2647 31 -0.8463 17

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-01 M 5,396 $8.99 a 15,822 direct 4.3724 7.5223 31.2647 31.2647 31 -0.8463 17

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-01 M 5,396 d 222,133 direct

    KORNITZER BENJAMIN - Officer CHIEF MED. & QUALITY OFFICER

    2023-02-03 16:09:06 -0500 2023-02-01 S 5,396 $21.76 d 10,426 direct yes 4.3724 7.5223 31.2647 31.2647 31 -0.8463 17

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AGILON HEALTH INC AGL 2023-03-24 15:45:03 UTC 4.4 0.42 70000
    AGILON HEALTH INC AGL 2023-03-24 15:15:03 UTC 4.4 0.42 15000
    AGILON HEALTH INC AGL 2023-03-24 14:45:03 UTC 4.4 0.42 10000
    AGILON HEALTH INC AGL 2023-03-24 14:15:03 UTC 4.4 0.42 10000
    AGILON HEALTH INC AGL 2023-03-24 13:45:03 UTC 4.0797 0.4903 6000
    AGILON HEALTH INC AGL 2023-03-24 13:15:04 UTC 4.0797 0.4903 100000
    AGILON HEALTH INC AGL 2023-03-24 12:45:03 UTC 4.0797 0.4903 100000
    AGILON HEALTH INC AGL 2023-03-23 22:15:04 UTC 4.0797 0.4903 100000
    AGILON HEALTH INC AGL 2023-03-23 21:45:04 UTC 4.0806 0.4894 100000
    AGILON HEALTH INC AGL 2023-03-23 21:15:04 UTC 4.0806 0.4894 100000
    AGILON HEALTH INC AGL 2023-03-23 20:45:03 UTC 4.0703 0.4997 100000
    AGILON HEALTH INC AGL 2023-03-23 20:15:03 UTC 4.0703 0.4997 15000
    AGILON HEALTH INC AGL 2023-03-23 19:45:03 UTC 4.0703 0.4997 15000
    AGILON HEALTH INC AGL 2023-03-23 19:15:03 UTC 4.0703 0.4997 15000
    AGILON HEALTH INC AGL 2023-03-23 18:45:04 UTC 3.9825 0.5875 15000
    AGILON HEALTH INC AGL 2023-03-23 18:15:03 UTC 3.9825 0.5875 15000
    AGILON HEALTH INC AGL 2023-03-23 17:45:03 UTC 3.9825 0.5875 20000
    AGILON HEALTH INC AGL 2023-03-23 17:15:03 UTC 3.9825 0.5875 20000
    AGILON HEALTH INC AGL 2023-03-23 16:45:04 UTC 3.9856 0.5844 80000
    AGILON HEALTH INC AGL 2023-03-23 16:15:03 UTC 3.9856 0.5844 20000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio AGL -20800.0 shares, $-545168.0 2021-09-30 N-PORT
    VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND AGL -4442.0 shares, $-88173.7 2022-10-31 N-PORT
    Steward Funds Inc- Steward Equity Market Neutral Fund AGL -16700.0 shares, $-331495.0 2022-10-31 N-PORT
    Nuveen Investment Trust II- Nuveen Equity Long/Short Fund AGL -19000.0 shares, $-333640.0 2022-11-30 N-PORT
    Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund AGL -12000.0 shares, $-193680.0 2022-12-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AGL -33100.0 shares, $-534234.0 2022-12-31 N-PORT
    TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund AGL -53025.0 shares, $-855823.5 2022-12-31 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund AGL -16633.0 shares, $-268456.62 2022-12-31 N-PORT
    AQR Funds- AQR Multi-Asset Fund AGL -14829.0 shares, $-239340.06 2022-12-31 N-PORT
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND AGL -289654.0 shares, $-4675015.56 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments